Postinfectious Neurologic Complications in COVID-19: A Complex Case Report

por Tiraboschi, Pietro, Xhani, Rubjona, Zerbi, Simone M., Corso, Angelo, Martinelli, Isabella, Fusi, Laura, Grampa, Giampiero, Lombardo, Andrea, Cavalcante, Paola, Cappelletti, Cristina, Andreetta, Francesca, Sironi, Alberto, Redolfi, Alberto, Muscio, Cristina
Publicado 2021

Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers

por Tolvanen, Tuula, Kalliokoski, Kari, Malaspina, Simona, Kuisma, Anna, Lahdenpohja, Salla, Postema, Ernst J., Miller, Matthew P., Scheinin, Mika
Publicado 2021

Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19

por Dadachova, Ekaterina
Publicado 2021

Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients

por Blazhenets, Ganna, Schroeter, Nils, Bormann, Tobias, Thurow, Johannes, Wagner, Dirk, Frings, Lars, Weiller, Cornelius, Meyer, Philipp T., Dressing, Andrea, Hosp, Jonas A.
Publicado 2021

V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy

por Schaefer, Wolfgang M., Knollmann, D., Meyer, Philipp T.
Publicado 2021

Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19

por Pillarsetty, Nagavarakishore, Carter, Lukas M., Lewis, Jason S., Reiner, Thomas
Publicado 2021

Addition of (131)I-MIBG to PRRT ((90)Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

por Bushnell, David L., Bodeker, Kellie L., O’Dorisio, Thomas M., Madsen, Mark T., Menda, Yusuf, Graves, Stephen, Zamba, Gideon K.D., O’Dorisio, M. Sue
Publicado 2021

Head-to-Head Comparison of (68)Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients

por Schilham, Melline G.M., Zamecnik, Patrik, Privé, Bastiaan M., Israël, Bas, Rijpkema, Mark, Scheenen, Tom, Barentsz, Jelle O., Nagarajah, James, Gotthardt, Martin
Publicado 2021

Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions

por Pantel, Austin R., Viswanath, Varsha, Muzi, Mark, Doot, Robert K., Mankoff, David A.
Publicado 2022

First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients

por Zhou, Xin, Jiang, Jinquan, Yang, Xue, Liu, Teli, Ding, Jin, Nimmagadda, Sridhar, Pomper, Martin G., Zhu, Hua, Zhao, Jun, Yang, Zhi, Li, Nan
Publicado 2022

Virtual Biopsy: Just an AI Software or a Medical Procedure?

por Murray, Jacob M., Wiegand, Bodo, Hadaschik, Boris, Herrmann, Ken, Kleesiek, Jens
Publicado 2022

Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution

por Peng, Lu, Nadia, Benabdallah, Wen, Jiang, Simons, Brian W., Hanwen, Zhang, Hobbs, Robert F., David, Ulmert, Baumann, Brian C., Pachynski, Russell K., Jha, Abhinav K., Thorek, Daniel L.J.
Publicado 2022

A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom

por Catana, Ciprian, Laforest, Richard, An, Hongyu, Boada, Fernando, Cao, Tuoyu, Faul, David, Jakoby, Bjoern, Jansen, Floris P., Kemp, Bradley J., Kinahan, Paul E., Larson, Peder, Levine, Michael A., Maniawski, Piotr, Mawlawi, Osama, McConathy, Jonathan E., McMillan, Alan B., Price, Julie C., Rajagopal, Abhejit, Sunderland, John, Veit-Haibach, Patrick, Wangerin, Kristen A., Ying, Chunwei, Hope, Thomas A.
Publicado 2022

Whole-Body Parametric Imaging of (18)F-FDG PET Using uEXPLORER with Reduced Scanning Time

por Wu, Yaping, Feng, Tao, Zhao, Yizhang, Xu, Tianyi, Fu, Fangfang, Huang, Zhun, Meng, Nan, Li, Hongdi, Shao, Fengmin, Wang, Meiyun
Publicado 2022

Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge

por Kumar, Arun, Moadel, Renée M., Haramati, Linda B., Ye, Kenny, Freeman, Leonard M., Zuckier, Lionel S.
Publicado 2022

Impact of (18)F-FET PET/MRI on Clinical Management of Brain Tumor Patients

por Brendle, Cornelia, Maier, Caroline, Bender, Benjamin, Schittenhelm, Jens, Paulsen, Frank, Renovanz, Mirjam, Roder, Constantin, Castaneda-Vega, Salvador, Tabatabai, Ghazaleh, Ernemann, Ulrike, la Fougère, Christian
Publicado 2022

(177)Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II...

por Pathmanandavel, Sarennya, Crumbaker, Megan, Yam, Andrew O., Nguyen, Andrew, Rofe, Christopher, Hovey, Elizabeth, Gedye, Craig, Kwan, Edmond M., Hauser, Christine, Azad, Arun A., Eu, Peter, Martin, Andrew J., Joshua, Anthony M., Emmett, Louise
Publicado 2022

A Comprehensive Assessment of (68)Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients

por Abghari-Gerst, Monica, Armstrong, Wesley R., Nguyen, Kathleen, Calais, Jeremie, Czernin, Johannes, Lin, David, Jariwala, Namasvi, Rodnick, Melissa, Hope, Thomas A., Hearn, Jason, Montgomery, Jeffrey S., Alva, Ajjai, Reichert, Zachery R., Spratt, Daniel E., Johnson, Timothy D., Scott, Peter J.H., Piert, Morand
Publicado 2022

PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma

por Lo, Andrea C., James, Lyndon P., Prica, Anca, Raymakers, Adam, Peacock, Stuart, Qu, Melody, Louie, Alex V., Savage, Kerry J., Sehn, Laurie H., Hodgson, David, Yang, Joanna C., Eich, Hans T.T., Wirth, Andrew, Hunink, M.G. Myriam
Publicado 2022

Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM

por Sharma, Sai Kiran, Suzuki, Maya, Xu, Hong, Korsen, Joshua A., Samuels, Zachary, Guo, Hongfen, Nemieboka, Brandon, Piersigilli, Alessandra, Edwards, Kimberly J., Cheung, Nai-Kong V., Lewis, Jason S.
Publicado 2022